WHAT IS EPIDUO® GEL?

Meet your face's new BFF

Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% is the only topical acne treatment that combines adapalene and benzoyl peroxide to help clear up the breakouts you have now and prevent future pimples from forming. The two ingredients have been proven to work better together than they do alone. Plus, having them together in a single treatment could mean fewer co-pays, more convenience and most of all, better results.

Benzoyl peroxide is one of the two effective ingredients in Epiduo® Gel. It kills the bacteria that cause breakouts and helps prevent pimples from coming back.

Adapalene is a type of retinoid, and the other ingredient in Epiduo® Gel. It unclogs blocked pores, helping to stop pimples from forming under the skin's surface and decreasing the redness, swelling and inflammation associated with pimples.

Together, they're basically your breakouts' worst nightmare.

Some people using Epiduo® Gel experience redness, scaling, dryness, stinging and/or burning—if that happens and it bothers you, get in touch with your doc.

TALK TO A DOC

You could pay no more than $35* and download the Blame Biology kit

Learn more

Track your progress

Get the mobile app

Help your teen take action

Make a plan

Get the doctor discussion guide

Download the PDF

Important Safety Information
Epiduo® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years and older. Apply to affected skin once daily, avoiding the eyes, lips and mucous membranes. The most common adverse events associated with use of Epiduo® Gel are redness, scaling, dryness, stinging and burning. In addition, you may also experience contact dermatitis and/or skin irritation. These side effects typically resolve during the first four weeks of treatment, but speak to your doctor if they persist. You should avoid excessive exposure to sunlight and sunlamps while using Epiduo® Gel, and use of sunscreen products and protective clothing is recommended. Do not use irritating topical products that contain resorcinol, salicylic acid or sulfur when using Epiduo® Gel. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

* Insured patients could pay no more than $35 for their Epiduo® Gel prescription (for one tube or pump, after primary insurance and the Epiduo Gel Instant Advantage Card). Restrictions may apply.

©2012 Galderma Laboratories, L.P. United States, All Rights Reserved. All trademarks are the property of their respective owners. This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information

Close

Epiduo® Gel is indicated for the topical treatment of acne vulgaris in patients 12 years and older. Apply to affected skin once daily, avoiding the eyes, lips and mucous membranes. The most common adverse events associated with use of Epiduo® Gel are redness, scaling, dryness, stinging and burning. In addition, you may also experience contact dermatitis and/or skin irritation. These side effects typically resolve during the first four weeks of treatment, but speak to your doctor if they persist. You should avoid excessive exposure to sunlight and sunlamps while using Epiduo® Gel, and use of sunscreen products and protective clothing is recommended. Do not use irritating topical products that contain resorcinol, salicylic acid or sulfur when using Epiduo® Gel. Epiduo® Gel has not been tested in pregnant or nursing women, or with the elderly. Pregnancy Category C. Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

TWITTER FACEBOOK GOOGLE BUZZ EMAIL
Close

SHARE THE NEWS

All fields are required.

Your Email Address:

Your Name:

Recipient's Email Address:

Send me a copy of this email

View our Privacy Policy